Monthly Communication Report

Organization:	Innovative Medicines Canada/Médicaments novateurs Canada
Associated registration:	957857-371-115
Communication date:	2024-09-24
Posted date:	2024-10-11

Designated Public Office Holders who participated in the communication:	Jessica  Fullerton , Senior Policy Advisor Office of the Minister of Intergovernmental Affairs, Infrastructure Canada (INFC) Footnote1
Subject Matter of the communication:	Consumer Issues,  Federal-Provincial Relations,  Health,  Industry,  Intellectual Property,  International Trade,  Research and Development,  Science and Technology,  Small Business,  Taxation and Finance
Responsible Officer who filed this communication report:	Bettina Hamelin
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication. The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed.
Footnote1  Indicates new information that was added through a monthly communications return.